These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Lineage-specific transcription factor aberrations in AML. Mueller BU, Pabst T. Cancer Treat Res; 2010 Sep; 145():109-25. PubMed ID: 20306248 [Abstract] [Full Text] [Related]
6. [Pathobiology of acute myeloid leukemia]. Christ O, Feuring-Buske M, Hiddemann W, Buske C. Med Klin (Munich); 2007 Apr 15; 102(4):290-5. PubMed ID: 17426932 [Abstract] [Full Text] [Related]
7. MicroRNAs: new players in AML pathogenesis. Nicoloso MS, Jasra B, Calin GA. Cancer Treat Res; 2010 Apr 15; 145():169-81. PubMed ID: 20306251 [No Abstract] [Full Text] [Related]
8. New agents for the treatment of acute myeloid leukemia. Tallman MS. Best Pract Res Clin Haematol; 2006 Apr 15; 19(2):311-20. PubMed ID: 16516128 [Abstract] [Full Text] [Related]
9. Acute myeloid leukemia and the Wnt pathway. Eaves CJ, Humphries RK. N Engl J Med; 2010 Jun 17; 362(24):2326-7. PubMed ID: 20554989 [No Abstract] [Full Text] [Related]
10. Insight into the molecular pathogenesis of myeloid malignancies. Haferlach T, Bacher U, Haferlach C, Kern W, Schnittger S. Curr Opin Hematol; 2007 Mar 17; 14(2):90-7. PubMed ID: 17255785 [Abstract] [Full Text] [Related]
11. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia. Engel ME, Hiebert SW. Cancer Treat Res; 2010 Mar 17; 145():127-47. PubMed ID: 20306249 [Abstract] [Full Text] [Related]
12. Molecularly targeted therapy in acute myeloid leukemia. Bernasconi P, Boni M, Cavigliano PM, Calatroni S, Giardini I, Rocca B, Zappatore R, Caresana M, Quarna J. Ann N Y Acad Sci; 2004 Dec 17; 1028():409-22. PubMed ID: 15650266 [Abstract] [Full Text] [Related]
13. Complexity of CEBPA dysregulation in human acute myeloid leukemia. Pabst T, Mueller BU. Clin Cancer Res; 2009 Sep 01; 15(17):5303-7. PubMed ID: 19706798 [Abstract] [Full Text] [Related]
14. Deregulation of signaling pathways in acute myeloid leukemia. Scholl C, Gilliland DG, Fröhling S. Semin Oncol; 2008 Aug 01; 35(4):336-45. PubMed ID: 18692684 [Abstract] [Full Text] [Related]
15. Role of nucleophosmin in acute myeloid leukemia. Meani N, Alcalay M. Expert Rev Anticancer Ther; 2009 Sep 01; 9(9):1283-94. PubMed ID: 19761432 [Abstract] [Full Text] [Related]
16. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation. Shen S, Passioura T, Symonds G, Dolnikov A. Exp Hematol; 2007 Jun 01; 35(6):908-19. PubMed ID: 17533045 [Abstract] [Full Text] [Related]
17. Human TM9SF4 Is a New Gene Down-Regulated by Hypoxia and Involved in Cell Adhesion of Leukemic Cells. Paolillo R, Spinello I, Quaranta MT, Pasquini L, Pelosi E, Lo Coco F, Testa U, Labbaye C. PLoS One; 2015 Jun 01; 10(5):e0126968. PubMed ID: 25961573 [Abstract] [Full Text] [Related]
18. The molecular biology of acute myeloid leukemia. Proto-oncogene expression and function in normal and neoplastic myeloid cells. Willman CL, Whittaker MH. Clin Lab Med; 1990 Dec 01; 10(4):769-96. PubMed ID: 2176959 [Abstract] [Full Text] [Related]
19. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice. Hirouchi T, Takabatake T, Yoshida K, Nitta Y, Nakamura M, Tanaka S, Ichinohe K, Oghiso Y, Tanaka K. Exp Hematol; 2008 Jul 01; 36(7):871-85. PubMed ID: 18375040 [Abstract] [Full Text] [Related]
20. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies. Graf M, Reif S, Hecht K, Kroell T, Nuessler V, Schmetzer H. Eur J Haematol; 2005 Dec 01; 75(6):477-84. PubMed ID: 16313259 [Abstract] [Full Text] [Related] Page: [Next] [New Search]